WO1997044486A1 - Identification of target bacteria by fluorescence detection of primer directed amplification products - Google Patents

Identification of target bacteria by fluorescence detection of primer directed amplification products Download PDF

Info

Publication number
WO1997044486A1
WO1997044486A1 PCT/US1997/007958 US9707958W WO9744486A1 WO 1997044486 A1 WO1997044486 A1 WO 1997044486A1 US 9707958 W US9707958 W US 9707958W WO 9744486 A1 WO9744486 A1 WO 9744486A1
Authority
WO
WIPO (PCT)
Prior art keywords
amplification
target
dna
pcr
cells
Prior art date
Application number
PCT/US1997/007958
Other languages
French (fr)
Inventor
William Mark Barbour
Susan Yen-Tee Tseng
Original Assignee
E.I. Du Pont De Nemours And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E.I. Du Pont De Nemours And Company filed Critical E.I. Du Pont De Nemours And Company
Priority to AU29391/97A priority Critical patent/AU2939197A/en
Priority to EP97923627A priority patent/EP0904408A1/en
Priority to CA002255760A priority patent/CA2255760A1/en
Priority to JP09542467A priority patent/JP2001501454A/en
Publication of WO1997044486A1 publication Critical patent/WO1997044486A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Definitions

  • This invention relates to the field of microbiology and molecular biology and particularly to methods for the detection of bacteria at the serotype level from complex matrices such as food.
  • Food borne bacterial contamination is a prominent health hazard in developed as well as developing countries. For example, two to three million cases of Salmonella food poisoning are estimated to occur each year in the United States. Acute symptoms of this disorder include nausea, vomiting, diarrhea, cold chills, fever, and exhaustion. About 2,000-3,000 (0.1%) people die each year in the United States from Salmonella poisoning, these victims usually including infants, the sick, and elderly.
  • Poultry, red meat, seafood, eggs and any foods which contain these products particularly have the potential to carry bacterial pathogens.
  • the challenge to a food microbiologist is to be able to recover and identify small numbers of these select pathogens from food products which often contain large numbers of a variety of other bacteria.
  • the traditional techniques for the detection and identification of microbes are based on the phenomenological or phenotype characteristics of the organism, such as its ability to metabolize certain specific nutrients, or its ability to bind with organism-specific antibodies. Such methods are intrinsically limited in their capabilities since (a) different organisms will require different growth and identification techniques; (b) the number of methods needed for detailed characterization of a number of different organisms will necessarily be unmanageably large; and, (c) the growth history and environment from which an organism is isolated can affect its phenotypic behavior. Most of the microbiological testing today is performed using conventional culture techniques according to Bacteriological Analytical Manual (BAM) procedures. These are manual methods involving many steps and taking up to 14 days to obtain definitive results for particular organisms.
  • BAM Bacteriological Analytical Manual
  • Culture-based testing begins with a food sample which is homogenized in a non-specific growth medium and allowed to incubate for 24 hours. This non-specific medium encourages growth of all microorganisms present in the sample and the recovery of injured organisms.
  • the next step, selective growth involves transfer of samples of non-selective broth into selective media tailored for specific target organisms. The samples are incubated for an additional 24-48 hours.
  • the selective media contain agents which suppress or even eliminate the growth of "background" organisms, while supporting the growth of the target pathogens.
  • several samples of the selective media are then streaked onto several solid, selective and differential media (agar). These agar media further suppress the growth of background organisms while supporting the growth of the target pathogen into isolated, differentiated colonies.
  • the plates After a specified period of incubation, the plates are usually read for evidence of growth of target bacteria.
  • the analysis of plated colonies is generally very time consuming, and often requires guesswork. If the plates contain clearly defined colonies having the appropriate morphological characteristics a battery of biochemical and/or serological tests must be performed for confirmatory identification and characterization of the suspects. If the colonies on the specific growth plate are not clearly defined, a re-streaking step may be necessary. If no colonies are observed after a specified incubation period, the food sample is considered to be negative for the specific pathogen.
  • Non-growth, biotechnology-based technologies offer a potential solution to the time intensive colony analysis in growth based methods.
  • These non-growth based technologies referred to as rapid methods, continue to be refined in order to provide rapid test results with greater assurance of quality products, translating into higher throughput and cost savings for both the food manufacturer and the testing lab.
  • ATP adenosine triphosphate
  • the most common immunological methods involve some form of an enzyme reporter linked to an antibody for detection of a pathogen-specific antigen.
  • the antibodies will bind to the antigen on the target microorganism on or in the reaction medium thus forming an antibody/antigen complex.
  • the antigen is then detected by addition of a
  • conjugate a second enzyme-labeled antibody that binds to the antibody/antigen complex to form a "sandwich”. After a separation or washing step, the enzyme concentration is measured by adding a substrate solution and measuring the resulting signal either visually or spectrophotometrically. A reading above a specified threshold indicates a positive result.
  • Enzyme-Linked Immunosorbent assays ELISAs
  • Enzyme-Linked Fluorescent assays ELFAs
  • Nucleic acid e.g., DNA or RNA
  • Nucleic acid probes are also useful for detection of specific pathogens such as Salmonella, Listeria and E. coli.
  • RNA probes that are specific for an organism are reacted with enriched samples that have been treated with a lysing reagent to release the target RNA from their cells.
  • Two different probes (a detector probe and a capture probe) which hybridize to adjacent regions of the target RNA are used.
  • the detector probe has a fluorescent label (fluorocein). while the capture probe has a "tail" of thymine nucleotides (“poly dT").
  • the two probes are allowed to hybridize with the target RNA.
  • the entire hybridization complex is then captured onto a plastic dipstick that is coated with poly dA molecules (which are complementary to the poly dT tail on the capture probe).
  • poly dA molecules which are complementary to the poly dT tail on the capture probe.
  • an enzyme-labeled anti-fluorocein antibody is added. Addition of a substrate produces a color change that can be detected in a spectrophotometer.
  • the entire assay process is similar in many respects to an ELISA but involves additional steps.
  • Probe assays are more complex and expensive than immunoassays, requiring many more protocol steps as well as a fully equipped laboratory. Both types of assays are time intensive, complex and require a battery of reagents for implementation. A simpler, more rapid method is needed.
  • genetic methods of identification involving the amplification of serotype-specific DNA or RNA provide the promise of a standardized method, where the same basic approach can be applied universally to the identification of any microorganism.
  • the presence or absence of any specific target microorganism can, in principle, be readily established at genus, species or subspecies level by establishing the presence or absence of appropriate genetic markers.
  • PCR polymerase chain reaction
  • Cano et al. (J. Appl. Bacteriol. (1993). 75(3), 247-53) utilize a L. monocytogenes and Salmonella specific primer pair to amplify target DNA from milk samples wherein the amplification products were labeled with ethidium bromide. Identification was made on the basis of hybridization to an immobilized fluorescent labeled probe.
  • Cano et al. (J. Food Prot. ( 1995), 58(6), 614-20) also teach a microwell assay for the detection of Listeria from food relying exclusively on amplification of a Listeria specific target DNA. The methods of Cano et al. do not teach selection of target bacteria from enriched colonies, and require extensive DNA isolation and purification prior to amplification.
  • PCR based methods of Cano et al. are capable of detecting food borne pathogens from food matrices, they still require either a hybridization step or extensive purification and isolation of genomic DNA subsequent to amplification of the target in order to detect the fluorescently labeled amplification products. Such steps add to the complexity of the assay and in some cases require the prior generation and immobilization of suitable fluorescently labeled hybridization probes.
  • the problem to be overcome therefore is to develop a method for the identification of pathogenic bacteria that is free of the encumbrances of the growth-based and immunologically-based identification methods for colony analysis and maximizes the benefits of primer directed amplification techniques.
  • the present invention provides a method for identifying a target bacterium in a sample analysate.
  • the analysate suspected of containing the target bacterium and having been cultured to produce at least one colony comprising the steps of: (i) picking at least a portion of a bacterial colony by means of an individual capillary tube; (ii) dispersing the cells comprising the colony of step (i) into a suitable dispersing buffer; (iii) lysing the dispersed cells of step (ii) by contacting the dispersed cells with an effective amount of lysis buffer such that the DNA contained within the dispersed cells is released; (iv) producing an amplification reaction mixture by contacting the DNA released in step (iii) with a nucleic acid amplification composition comprising amplification primers useful for amplification of target DNA; (v) performing primer directed amplification on the released DNA of step (iii) to produce an amplification product mixture; and (vi) analyzing the amplification product mixture for the presence of target amplification products wherein the target amplification products contain an intercalating agent, the intercalating
  • Figure 1 is a histogram of the results of analysis of Salmonella and background bacteria in fluorescence PCR assays. The assays were performed in the presence of the intercalating dye YO-PRO- 1 TM in order to determine the threshold fluorescence of labeled Salmonella-specific amplification products.
  • DETAILED DESCRIPTION OF THE INVENTION The following terms may be used for interpretation of the claims and specification.
  • target nucleic acid or "target DNA” refers to a nucleic acid fragment that is detected by the present detection method and is indicative of the presence of a target bacterium.
  • the target DNA is typically a unique portion of the target bacteria genome and specifically distinguishes the target bacteria from all other bacteria.
  • amplification primer or simply “primer” refers to a nucleic acid fragment or sequence that is complementary to at least one section along a strand of the target nucleic acid, wherein the purpose of the primer is to sponsor and direct nucleic acid replication of a portion of the target nucleic acid along that strand.
  • Primers can be designed to be complementary to specific segments of a targeted sequence. In PCR, for example, each primer is used in combination with another primer forming a "primer set” or “primer pair”; this pair flanks the targeted sequence to be amplified.
  • primer is used generally by Applicants to encompass any sequence-binding oligonucleotide which functions to initiate the nucleic acid replication process.
  • amplification product refers to specific DNA fragments generated from any primer-directed amplification reaction.
  • target amplification product or “amplified target” refers to double stranded DNA (“dsDNA”) that is generated from a specific target nucleic acid to be identified and quantified by means of primer directed amplification.
  • Target amplification products may be produced by any primer directed amplification method. Further, it is understood that all methods of preparing suitable target amplification products are sufficiently controlled so as to eliminate spurious non-target amplification artifacts such as primer-dimer fragments, triple helices and the like.
  • Target amplification products will generally be dsDNA and will be amenable to being bound by intercalating agents.
  • primer-directed amplification refers to any of a number of methods known in the art that result in amplification of nucleic acid molecules using the recognition of a specific nucleic acid sequence or sequences to initiate an amplification process. Applicants contemplate that amplification may be accomplished by any of several schemes known in this art. including but not limited to the polymerase chain reaction (PCR) or ligase chain reaction (LCR) and strand displacement amplification.
  • PCR polymerase chain reaction
  • LCR ligase chain reaction
  • nucleic acid amplification composition refers to a composition comprising the ingredients necessary for performing nucleic acid amplification.
  • Nucleic acid amplification compositions may be provided in a variety of forms including liquid mixtures as well as tableted reagents. If PCR methodology is selected, the amplification composition would include, for example, nucleotide triphosphates, two primers with appropriate sequences, DNA polymerase. suitable buffers and proteins.
  • target bacteria refers to the bacteria from which the target DNA is amplified.
  • Target bacteria may be members of defined mixed cultures, or exist as contaminants in complex matrices.
  • Target bacteria of particular interest are food-borne pathogens.
  • non-target bacteria will be used interchangeably with the term “background bacteria” and will refer to any bacteria that are found in the presence of the target bacteria but are not the target bacteria. Non-target bacteria may or may not be related genetically or biochemically to the target bacteria. Those non- target bacteria of most interest in the context of the present application are non- pathogenic food-borne bacteria.
  • picking refers to the process of removing a specified portion of a bacterial colony. As disclosed herein, the instant method provides a means whereby a specific and uniform number of bacterial cells is picked, thus leading to reproducibility of the instant method while minimizing spurious, non-specific results.
  • the term "dispersing buffer” means a buffer that maintains the cells intact and is useful for the dispersion of individual cells from a bacterial colony. Isotonic buffers such as buffered saline are particularly suitable.
  • lysis buffer refers to any aqueous solution suitable for use in the lysing of bacterial cells and releasing the cellular DNA.
  • amplification reaction mixture refers to the mixture of all the reagents and cellular material necessary to perform primer directed amplification of target DNA. Typically the amplification reaction mixture results from the mixing of the lysis buffer containing cellular DNA and the nucleic acid amplification composition.
  • amplification product mixture refers to the mixture formed after primer directed amplification has been performed on the amplification reaction mixture. If target DNA is present in the amplification reaction mixture, then the amplification product mixture will contain amplification products.
  • intercalating agent means a temperature-sensitive fluorescent agent capable of intercalating into nucleic acid molecules.
  • intercalating agent will be used interchangeably with the term “dye”. Intercalating agents emit a fluorescent signal when intercalated into the nucleic acid and will not generate any signal when not intercalated. Typical of intercalating agents are the unsymetrical cyanine dyes such as YO-PRO-1 TM, available from Molecular Probes. Inc. (Eugene, OR. USA).
  • Threshold fluorescence refers to the level of fluorescence above which the presence of dye-labeled target amplification products are confirmed. Threshold fluorescence is determined empirically by the analysis of a multiplicity of primer directed amplification reactions performed on both target and non-target bacteria.
  • matrix or “complex matrix” will refer to any organic or inorganic material that will support the growth of a variety of microorganisms.
  • the matrices of the present invention will be complex in nature and will comprise of a variety of different organic growth-supporting substances. Typical matrices include components of food matter, biological tissues, organic waste products, and the like.
  • pre-enrichment growth or “pre-enrichment culture” refers to the growth of target and non-target bacteria isolated from a complex matrix in a medium designed to resuscitate both classes of bacteria which have been injured or compromised by the sampling process.
  • Pre-enrichment media will refer to cither a liquid or solid media designed to encourage the growth of both target and background bacteria.
  • the pre-enrichment media of the present invention is buffered to allow for the variations in pH of a variety of different food matrices.
  • selective growth or “selective enrichment culture” refers to the growth of target and non-target bacteria isolated from a pre-enrichment culture in a selective media.
  • the selective medium is designed to specifically encourage the growth of the target bacteria over the contaminating background or non-target bacteria.
  • Selective growth media will refer to either a solid or liquid growth media specifically formulated to enhance the growth of the target bacteria and discourage the growth of background bacteria. Selective media capitalize on the specific nutrient requirements and the resistance to certain selective agents of the target bacteria to produce selective growth.
  • sample analysate refers to a sample of bacteria taken from a selective enrichment culture.
  • Utility Statement The instant invention affords detection of target organisms, particularly bacteria, in the presence of contaminating food matrices and non-target bacteria.
  • the method is particularly useful for the detection of pathogenic bacteria in the food preparation, agricultural and live stock industries, and also has application for medical and veterinary diagnostics.
  • the present invention defines a process for the detection of target bacteria from a complex matrix by means of (i) target enrichment, consisting of consecutive pre-enrichment and selective cultures followed by (ii) colony picking, (iii) cell lysis, and finally (iv) amplification of target DNA.
  • Amplification products are detected by means of a signal generated by an intercalating agent bound to the target amplification products.
  • the minimum industry standard for the detection of food-borne bacterial pathogens is a method that will reliably detect the presence of one pathogen cell in 25 g of food matrix.
  • enrichment methods and media have been developed to enhance the growth of the target pathogen cell in order to facilitate its detection.
  • the first step is a "pre-enrichment step" wherein the food sample is enriched in a nutritious. nonseiective broth medium to restore injured target cells to a stable condition and to promote growth.
  • a sample of the pre-enrichment broth is added to a selective enrichment broth, wherein the sample is further enriched in a growth- promoting medium containing selective reagents.
  • Selective enrichment broth allows a continued increase of target bacteria while simultaneously restricting proliferation of most other background, non-target bacteria.
  • Examples of selective media useful for the selective enrichment of Salmonella are tetrathionate broth and selenite cysteine broth. Media may be defined for virtually any known target bacteria, see for example Bacteriological Analytical Manual. 8th Edition. Association of Official Analytical Chemists. Arlington, VA (1995).
  • Solid media are selected so as to further enrich the growth of target bacteria while inhibiting the growth of background or non-target species.
  • a variety of media are known in the art.
  • media that are particularly suited for the selection of Salmonella over background bacteria include xylose lysine desoxycholate (XLD). bismuth sulfite (BS), and Hektoen enteric (HE) agars.
  • XLD xylose lysine desoxycholate
  • BS bismuth sulfite
  • HE Hektoen enteric
  • Colonies grown on solid media are picked, lysed and submitted to a protocol for primer directed amplification of target DNA.
  • the method of picking the colonies is an essential element of the present invention.
  • the present method allows for the optimum number of cells to be submitted to the primer directed amplification protocol. Higher numbers of cells result in excessive fluorescent background and the introduction of materials known to inhibit DNA amplification. Lower numbers of cells result in insufficient amplification of target DNA.
  • Colonies were picked using a 5 uL glass capillary tube.
  • Capillary tubes having an outside diameter (“O.D.") of between 0.026 in. and 0.0965 in are preferred in the present invention where an O.D. of about 0.0375 in. is most preferred.
  • the particular capillary chosen for the experiments described herein was a 5 uL Microcap capillary (Drummond Scientific Co., Broomall, PA) of about 1.26 inches in length. Picking colonies with this device delivered between lxl 0 6 and 2x10 7 cells to the lysis buffer.
  • Other design aspects of these capillaries lend utility.
  • the small size, both in length and diameter allow placement of at least 12 capillaries in a single tube for resuspension of the collected cells by vortexing.
  • this picking process eliminates the need for quantification methods such as optical density measurements, commonly used in biochemical assays to deliver the required number of cells. Also, the diameter of the capillary acts as a gauge which is used to determine whether a colony is large enough to yield the required number of cells. Finally, the inert nature of glass guards against release of PCR inhibitory chemicals from the picking device.
  • Target DNA may be from any source where it is of value to discern the presence of a double-stranded nucleic acid fragment that is unique to a particular organism or is defining for a specific genetic trait.
  • target DNA is amplified to produce target amplification products from pathogenic bacterial organisms known to contaminate food.
  • pathogenic bacterial organisms known to contaminate food.
  • Of particular interest will be DNA isolated from organisms such as members of the following genera: Listeria, Salmonella, Clostridium and Escherichia.
  • amplification may be accomplished by any of several schemes known in this art, including but not limited to the polymerase chain reaction (PCR), ligase chain reaction (LCR) or strand displacement amplification (SDA).
  • PCR polymerase chain reaction
  • LCR ligase chain reaction
  • SDA strand displacement amplification
  • the amplification composition would include for example, nucleotide triphosphates.
  • two primers with appropriate sequences, suitable buffers, DNA polymerase and proteins are provided in U.S. Patent No. 4,683,202 and U.S. Patent No. 4,683,195.
  • LCR methodology is selected, then the nucleic acid amplification compositions would comprise, for example, a thermostable ligase. e.g.. T.
  • aquaticus ligase two sets of adjacent ohgonucleotides wherein one member of each set is complementary to each of the target strands. Tris-HCl buffer, KCl, EDTA. NAD, dithiothreitol and salmon sperm DNA. (See. for example. Tabor. S. and Richardson. C. C. (1985) Proc. Acad. Sci. USA 82, 1074- 1078). If the SDA methodology is employed, amplification may be accomplished using either one or two short primers containing a site for Hindi digestion, an exonuclease deficient DNA polymerase, Hindi restriction enzyme and the bases dGTP, dCTP.
  • dTTP and deoxyadenosine 5'fa-thio]triphosphate (dATP[aS].
  • SDA protocol including the necessary materials is outlined in Walker, et al., Proc. Natl. Acad. Sci. U.S.A., 89, 392, (1992).
  • sample tablet will contain all the necessary reagents to amplify a specified target DNA, including appropriate primers and a suitable DNA polymerase.
  • Positive control tablets will contain all the reagents encompassed within the sample tablet with the addition of a specified amount of target DNA. Addition of the positive control tablet into the PCR reaction will result in the amplification of the target DNA within the tablet thereby providing a reference for both the PCR reaction and for fluorescence detection.
  • the "negative control” tablet contains all the reagents encompassed in the sample tablet with the exception of the DNA polymerase. The presence of the negative control tablet in the PCR reaction serves as a reference control for background fluorescence.
  • the present method uses an intercalating agent capable of binding to dsDNA and emitting a fluorescent signal distinguishable from the signal generated when unbound or bound to single stranded DNA.
  • intercalating agents include propidium iodide (PI) and ethidium bromide (EB) (Sailer et al..
  • Cyanine dyes are particularly suited for use in the present method since they possess binding constants for DNA low enough not to inhibit amplification by most primer directed amplification methods but high enough to still give a detectable signal.
  • Preferred binding constants for the cyanine dyes useful in the present invention are from about from about lxl 0 4 to about 5xl0 5 (molar 1 ).
  • cyanine dye YO-PRO-1TM Quinolinium. 4-[(3- methyl-2(3H)-benzoxazolylidenc)methyl]-l-[3-(trimethylammonio)- propyl]-. diiodide) available from Molecular Probes, Inc. (Eugene. OR. USA).
  • YO-PRO- 1 TM is particularly suited for use in the present invention due to its high extinction coefficient, near zero fluorescence when unbound, suitable binding affinity to double-stranded DNA and reasonable photostability.
  • YO-PRO-1TM is sufficiently resistant to the elevated processing temperatures at the time intervals used to provide an effective signal in use.
  • the intercalating agent can be provided at any step of the method prior to fluorescence detection.
  • the intercalating agent may be present in the buffer into which cells comprising picked bacterial colonies are dispersed.
  • the intercalating agent can be present in the buffer containing the lysis reagent.
  • the intercalating agent can be introduced into the method as a component of the amplification composition.
  • the intercalating agent can be added to the amplification product mixture just prior to analysis by fluorescence detection.
  • the intercalating agent chosen for use in the instant method may be temperature sensitive; i.e., the binding affinity of the intercalating agent for dsDNA and hence the magnitude of the fluorescent signal emitted may vary with temperature. Accordingly, it is readily apparent to one skilled in the art that instrument calibration, positive and negative controls and samples must all be assayed under controlled temperature conditions.
  • FIUc the calculated fluorescence value
  • FlUt the measured fluorescence value at a given ambient temperature (t)
  • TCF ((0.25 + 0.05(t))/l .45. This algorithm produces a constant result over a temperature range of 15-35°C.
  • nucleic acid composition is in liquid form, suitable buffers known in the art are used. (Sambrook, J. et al., Molecular Cloning: A Laboratory Manual, Second Edition. Cold Spring Harbor Laboratory Press (1989)). If the composition is contained in a tabletted reagent, then typical tabletting reagents are included as described in PCT US96/15085.
  • the intercalating agent YO-PRO-1TM can be included in the PCR reaction.
  • YO-PRO-1 TM is added to the sample to give a final dye concentration of about 3 uM. Thermocycling proceeds according to typical cycling times and temperatures.
  • the method of the invention begins with the collection of samples suspected of containing target bacteria and submission of those samples to target enrichment protocols. Samples are first cultured in a non-selective pre- enrichment medium and incubated for about 24 hours at about 37 °C. Following pre-enrichment, samples of the pre-enrichment culture are diluted into a selective medium to enrich the growth of the target bacteria. Aliquots of the selective culture are then streaked on appropriate solid media for colony generation. A defined number of bacteria are then picked by means of an individual 5 uL capillary tube from at least one colony on each plate. Capillary tubes from each pick are deposited in a container and immersed in an suitable dispersing buffer. Optionally the dispersing buffer may contain an intercalating agent capable of intercalating into DNA and emitting a fluorescent signal. The container is then sealed and agitated to disperse the cells from the capillary tubes into the amplification composition.
  • lysis buffer may optionally contain an effective concentration of intercalating agent. Lysis of the cells may occur by any method, including differential osmotic pressure, mechanical means such as sonication or heat.
  • Reagents necessary for the primer directed amplification (typically PCR) of target DNA may be added after ceil lysis.
  • Such reagents will typically include nucleotide triphosphates, two primers with appropriate sequences, suitable buffers, DNA polymerase and proteins. These reagents may be provided in either solution or tableted form. Preferred are the use of tableted PCR reagents.
  • Three types of tablets are used: a sample tablet, a positive control tablet and a negative control tablet. Sample tablets contain all reagents necessary for the amplification of the target. Positive control tablets contain the same reagents as the sample tablet with the addition of a specified amount of target DNA. Negative control tablets contain the same reagents as the sample tablet with the exception of the DNA polymerase.
  • the positive control tablet serves as a check on the efficacy of the reaction as well as a monitor of expected fluorescence levels.
  • the negative control tablet is an indication of background fluorescence produced by non ⁇ productive PCR reagents.
  • the amplification protocol is performed in a sealed reaction vessel. Sealing of the vessel is important to prevent carryover contamination. If target DNA is present, amplification products are produced and products are detected and quantified.
  • kits A typical kit will provide all consumable/disposable elements required for multiple analyses.
  • Components for a Kit may include for example. Microcap Tubes, Sample Tube Assemblies consisting of clear PCR tubes with PCR caps having sample PCR tableted reagents enclosed, Lysis Buffer, a Control Tablet Package consisting of a first set of capped PCR tubes having negative control PCR tableted reagents enclosed and a second set of capped PCR tubes having positive control PCR tableted reagents enclosed, a YO-PRO-1TM Package, and Calibration Tubes consisting of a first set of tubes filled with a 1 :258 dilution of Estapor® fluorescent pink polystyrene particles( Stock Code D0001852CF; Bangs Laboratories, Inc., Carmel, IN), and a second set of tubes filled with lysis buffer.
  • the cyanine intercalating agent YO-PRO-1TM was obtained from Molecular Probes (Eugene. OR).
  • Salmonella-specific PCR reagents used in the following examples were obtained from Qualicon, L.L.C.. Wilmington. DE (part no. 17410530) and are included in the Salmonella screening kit (catalog number 17720519).
  • Salmonella strains were used in the examples provided herein: S. enteritidis (737), S. typhimurium (897), S. virchow (1247). S. hadar ( 1268). 5. kedougou ( 1254), 5. Heidelberg ( 1239), 5. montevideo ( 1260). and S. infantis (732).
  • Non-target background organisms employed herein include
  • Citrobacter diversus (2560). Citrobacter spp. (217). £ coli (5108), £ co// (51 1 1 ), Hafnia alvei (4965), Hafnia alvei (2010). Proteus mirabilis (2321 ), and Proteus vulgaris (2323). All bacterial strains were obtained from the Qualicon L.L.C. culture collection. Numbers in parentheses indicate internal Qualicon L.L.C. culture designations. Solid Selective Media
  • XLD xylose iysine desoxycholate
  • BS bismuth sulfite
  • HE Hektoen enteric
  • Lysis buffer used in this example consisted of 50 mM Tris. 28 mM KCl , 3 mM MgCl 2 , 0.1% Triton X-100, pH 8.3 containing 3 uM YO-PRO- 1 TM.
  • PCR reagent components consisted of:
  • the PCR buffer was comprises 50 mM Tris. 28 mM KCl, 0.1 % Tween-20 buffer. pH 8.3. Fluorometer Calibration
  • a fluorometer equipped with a tungsten-halogen lamp, a 485 nm excitation filter and a 535 nm emission filter was used for detection of fluorescence emitted from amplification product.
  • Reagents used for the calibration of the fluorometer are as follows: (i) DNA standard: 500 bp double strand DNA fragment (BioVentures. Inc.; Catalogue No. M500).
  • lysis/dye buffer lysis buffer containing 3 uM YO-PRO- 1 TM.
  • the DNA standard was prepared at three different concentrations: 0 ng DNA, 200 ng DNA/50 uL and 400 ng DNA/50 uL.
  • a standard curve was generated by measuring the fluorescence emitted from the three concentrations of DNA standards. The mean value of all three readings for each concentration was calculated and the results are tabulated below in Table I:
  • C. Lysis/Dye solution was prepared as follows.
  • a 3 uM YO-PRO-1TM solution was prepared by adding 1.75 mL of lysis buffer into the YO-PRO- 1 TM tube (as received from the manufacturer).
  • PCR reagents tubes were prepared by pipetting 1 mL lysis buffer and 200 uL of the 3 uM YO-PRO-1 TM solution into tubes containing either a sample PCR tablet (experimental), a positive control tablet or a negative control tablet.
  • D. Cell picking procedure was performed as follows.
  • XLD, HE and BS plates Citrobacter diversus (2560), Citrobacter spp (217),
  • Colonies were picked from the culture plates as follows: 1) The capillary container was held upside down and a capillary was removed from the hole by grasping one end. making sure not to touch the other end of the capillary.
  • Tubes were incubated for 10 min in a water bath at 95°C.
  • thermo cycler was programmed as follows:
  • the PCR Fluorescence threshold value tor Salmonella was previously determined to be 1 5 FIU As an internal control, the positive control PCR fluorescence reading was maintained above threshold and the negative control PCR was maintained below the threshold
  • MOLECULE TYPE DNA (uenomic) (in) HYPOTHETICAL: NO

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention describes a method for the identification of a target bacteria from a sample isolated from a complex matrix such as food and enriched for the presence of the target. The method employs a method of picking colonies cultured from the sample such that the DNA from the cells may be immediately subjected to primer directed amplification after picking and without further processing. Amplification products are detected on the basis of detection of an intercalated fluorescent dye. Fluorescent signal generated from the amplification products is easily differentiated over background.

Description

TITLE
IDENTIFICATION OF TARGET BACTERIA BY FLUORESCENCE
DETECTION OF PRIMER DIRECTED AMPLIFICATION PRODUCTS
FIELD OF THE INVENTION This invention relates to the field of microbiology and molecular biology and particularly to methods for the detection of bacteria at the serotype level from complex matrices such as food.
BACKGROUND OF THE INVENTION Food borne bacterial contamination is a prominent health hazard in developed as well as developing countries. For example, two to three million cases of Salmonella food poisoning are estimated to occur each year in the United States. Acute symptoms of this disorder include nausea, vomiting, diarrhea, cold chills, fever, and exhaustion. About 2,000-3,000 (0.1%) people die each year in the United States from Salmonella poisoning, these victims usually including infants, the sick, and elderly.
Poultry, red meat, seafood, eggs and any foods which contain these products particularly have the potential to carry bacterial pathogens. The challenge to a food microbiologist is to be able to recover and identify small numbers of these select pathogens from food products which often contain large numbers of a variety of other bacteria.
The traditional techniques for the detection and identification of microbes are based on the phenomenological or phenotype characteristics of the organism, such as its ability to metabolize certain specific nutrients, or its ability to bind with organism-specific antibodies. Such methods are intrinsically limited in their capabilities since (a) different organisms will require different growth and identification techniques; (b) the number of methods needed for detailed characterization of a number of different organisms will necessarily be unmanageably large; and, (c) the growth history and environment from which an organism is isolated can affect its phenotypic behavior. Most of the microbiological testing today is performed using conventional culture techniques according to Bacteriological Analytical Manual (BAM) procedures. These are manual methods involving many steps and taking up to 14 days to obtain definitive results for particular organisms.
Culture-based testing begins with a food sample which is homogenized in a non-specific growth medium and allowed to incubate for 24 hours. This non-specific medium encourages growth of all microorganisms present in the sample and the recovery of injured organisms. The next step, selective growth, involves transfer of samples of non-selective broth into selective media tailored for specific target organisms. The samples are incubated for an additional 24-48 hours. The selective media contain agents which suppress or even eliminate the growth of "background" organisms, while supporting the growth of the target pathogens. In the final growth step, several samples of the selective media are then streaked onto several solid, selective and differential media (agar). These agar media further suppress the growth of background organisms while supporting the growth of the target pathogen into isolated, differentiated colonies.
After a specified period of incubation, the plates are usually read for evidence of growth of target bacteria. The analysis of plated colonies is generally very time consuming, and often requires guesswork. If the plates contain clearly defined colonies having the appropriate morphological characteristics a battery of biochemical and/or serological tests must be performed for confirmatory identification and characterization of the suspects. If the colonies on the specific growth plate are not clearly defined, a re-streaking step may be necessary. If no colonies are observed after a specified incubation period, the food sample is considered to be negative for the specific pathogen.
Problems with the culture approach requiring the analysis of plated colonies are legion and include: elementary levels of information, inconsistent results, proliferation of methods and reagents unique to the target organism, long turn-around time, labor intensive protocols and operator technique dependency. Non-growth, biotechnology-based technologies offer a potential solution to the time intensive colony analysis in growth based methods. These non-growth based technologies, referred to as rapid methods, continue to be refined in order to provide rapid test results with greater assurance of quality products, translating into higher throughput and cost savings for both the food manufacturer and the testing lab.
Two alternate test methods, immunoassay and nucleic acid probes, are increasingly used. Other emerging technologies are adenosine triphosphate (ATP) bioluminescence, conductance and impedance methods, flow cytometry, biosensors and DNA amplification.
The most common immunological methods involve some form of an enzyme reporter linked to an antibody for detection of a pathogen-specific antigen. In an immuno-reaction, the antibodies will bind to the antigen on the target microorganism on or in the reaction medium thus forming an antibody/antigen complex. The antigen is then detected by addition of a
"conjugate", a second enzyme-labeled antibody that binds to the antibody/antigen complex to form a "sandwich". After a separation or washing step, the enzyme concentration is measured by adding a substrate solution and measuring the resulting signal either visually or spectrophotometrically. A reading above a specified threshold indicates a positive result. Enzyme-Linked Immunosorbent assays (ELISAs) and Enzyme-Linked Fluorescent assays (ELFAs) are typical. Nucleic acid (e.g., DNA or RNA) probes are also useful for detection of specific pathogens such as Salmonella, Listeria and E. coli. These assays use a calorimetric format to detect ribosomal RNA (thousands of copies of RNA are in each ceil as opposed to a single copy of DNA). Therefore, the use of RNA as a target increases assay sensitivity. As with immunoassays, an enrichment step is still required. RNA probes that are specific for an organism are reacted with enriched samples that have been treated with a lysing reagent to release the target RNA from their cells. Two different probes (a detector probe and a capture probe) which hybridize to adjacent regions of the target RNA are used. The detector probe has a fluorescent label (fluorocein). while the capture probe has a "tail" of thymine nucleotides ("poly dT"). The two probes are allowed to hybridize with the target RNA. The entire hybridization complex is then captured onto a plastic dipstick that is coated with poly dA molecules (which are complementary to the poly dT tail on the capture probe). After a washing step, an enzyme-labeled anti-fluorocein antibody is added. Addition of a substrate produces a color change that can be detected in a spectrophotometer. The entire assay process is similar in many respects to an ELISA but involves additional steps.
Probe assays are more complex and expensive than immunoassays, requiring many more protocol steps as well as a fully equipped laboratory. Both types of assays are time intensive, complex and require a battery of reagents for implementation. A simpler, more rapid method is needed. In contrast to immunological and probe technology, genetic methods of identification involving the amplification of serotype-specific DNA or RNA provide the promise of a standardized method, where the same basic approach can be applied universally to the identification of any microorganism. Thus, the presence or absence of any specific target microorganism can, in principle, be readily established at genus, species or subspecies level by establishing the presence or absence of appropriate genetic markers.
Methods of identifying food borne bacteria based on amplification of specific portions of a bacterial genome by polymerase chain reaction (PCR) are known in the art. For example Maher et al. (Mol. Cell. Probes (1995), 9(4), 265-76) teach a method for the identification of pathogenic bacteria such as
Listeria by fluorescently detecting PCR products generated with species-specific primer sets. Similarly Yue et al. (U.S. 5,321,130), Higuchi R. G. (CA 2067909) and Sutherland et al. (U.S. 5,563,037) all disclose bacterial detection methods using the incorporation of cyanine dyes into PCR amplification products for the detection of serotype specific products. Bassler et al. (Appl. Environ. Microbiol. (1995), 61(10), 3724-8) teach a Listeria detection method which relies on the hydrolysis of an internal flouorgenic probe to monitor the amplification of the target. Methods such as these are highly specific and sensitive but require a clean sample of target DNA. Application of these methods to analysis of food samples would require many of the cumbersome growth methods described above to produce a sample free of contaminating non-specific DNA (which will result in high background fluorescence) and other materials that will inhibit the PCR reaction.
In spite of the difficulties associated with fluorescence-based PCR amplification of target DNA from bacteria isolated from food, several methods have been developed. For example Cano et al. (J. Appl. Bacteriol. (1993). 75(3), 247-53) utilize a L. monocytogenes and Salmonella specific primer pair to amplify target DNA from milk samples wherein the amplification products were labeled with ethidium bromide. Identification was made on the basis of hybridization to an immobilized fluorescent labeled probe. Cano et al. (J. Food Prot. ( 1995), 58(6), 614-20) also teach a microwell assay for the detection of Listeria from food relying exclusively on amplification of a Listeria specific target DNA. The methods of Cano et al. do not teach selection of target bacteria from enriched colonies, and require extensive DNA isolation and purification prior to amplification.
Although the PCR based methods of Cano et al., are capable of detecting food borne pathogens from food matrices, they still require either a hybridization step or extensive purification and isolation of genomic DNA subsequent to amplification of the target in order to detect the fluorescently labeled amplification products. Such steps add to the complexity of the assay and in some cases require the prior generation and immobilization of suitable fluorescently labeled hybridization probes. The problem to be overcome therefore is to develop a method for the identification of pathogenic bacteria that is free of the encumbrances of the growth-based and immunologically-based identification methods for colony analysis and maximizes the benefits of primer directed amplification techniques. Applicants have solved the stated problem by developing a method wherein colonies of target and non-target bacteria isolated from food samples may be picked and directly submitted to primer directed amplification techniques for the generation and fluorescence detection of target specific amplification products. SUMMARY OF THE INVENTION The present invention provides a method for identifying a target bacterium in a sample analysate. the analysate suspected of containing the target bacterium and having been cultured to produce at least one colony, the method comprising the steps of: (i) picking at least a portion of a bacterial colony by means of an individual capillary tube; (ii) dispersing the cells comprising the colony of step (i) into a suitable dispersing buffer; (iii) lysing the dispersed cells of step (ii) by contacting the dispersed cells with an effective amount of lysis buffer such that the DNA contained within the dispersed cells is released; (iv) producing an amplification reaction mixture by contacting the DNA released in step (iii) with a nucleic acid amplification composition comprising amplification primers useful for amplification of target DNA; (v) performing primer directed amplification on the released DNA of step (iii) to produce an amplification product mixture; and (vi) analyzing the amplification product mixture for the presence of target amplification products wherein the target amplification products contain an intercalating agent, the intercalating agent added at any time before step (vi). BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a histogram of the results of analysis of Salmonella and background bacteria in fluorescence PCR assays. The assays were performed in the presence of the intercalating dye YO-PRO- 1 ™ in order to determine the threshold fluorescence of labeled Salmonella-specific amplification products. DETAILED DESCRIPTION OF THE INVENTION The following terms may be used for interpretation of the claims and specification. The term "target nucleic acid" or "target DNA" refers to a nucleic acid fragment that is detected by the present detection method and is indicative of the presence of a target bacterium. The target DNA is typically a unique portion of the target bacteria genome and specifically distinguishes the target bacteria from all other bacteria. The term "amplification primer" or simply "primer" refers to a nucleic acid fragment or sequence that is complementary to at least one section along a strand of the target nucleic acid, wherein the purpose of the primer is to sponsor and direct nucleic acid replication of a portion of the target nucleic acid along that strand. Primers can be designed to be complementary to specific segments of a targeted sequence. In PCR, for example, each primer is used in combination with another primer forming a "primer set" or "primer pair"; this pair flanks the targeted sequence to be amplified. The term "primer", as such, is used generally by Applicants to encompass any sequence-binding oligonucleotide which functions to initiate the nucleic acid replication process.
The term "amplification product" refers to specific DNA fragments generated from any primer-directed amplification reaction. The term "target amplification product" or "amplified target" refers to double stranded DNA ("dsDNA") that is generated from a specific target nucleic acid to be identified and quantified by means of primer directed amplification. Target amplification products may be produced by any primer directed amplification method. Further, it is understood that all methods of preparing suitable target amplification products are sufficiently controlled so as to eliminate spurious non-target amplification artifacts such as primer-dimer fragments, triple helices and the like. Target amplification products will generally be dsDNA and will be amenable to being bound by intercalating agents.
The term "primer-directed amplification" refers to any of a number of methods known in the art that result in amplification of nucleic acid molecules using the recognition of a specific nucleic acid sequence or sequences to initiate an amplification process. Applicants contemplate that amplification may be accomplished by any of several schemes known in this art. including but not limited to the polymerase chain reaction (PCR) or ligase chain reaction (LCR) and strand displacement amplification.
The term "nucleic acid amplification composition" refers to a composition comprising the ingredients necessary for performing nucleic acid amplification. Nucleic acid amplification compositions may be provided in a variety of forms including liquid mixtures as well as tableted reagents. If PCR methodology is selected, the amplification composition would include, for example, nucleotide triphosphates, two primers with appropriate sequences, DNA polymerase. suitable buffers and proteins.
The term "target bacteria" refers to the bacteria from which the target DNA is amplified. Target bacteria may be members of defined mixed cultures, or exist as contaminants in complex matrices. Target bacteria of particular interest are food-borne pathogens.
The term "non-target bacteria" will be used interchangeably with the term "background bacteria" and will refer to any bacteria that are found in the presence of the target bacteria but are not the target bacteria. Non-target bacteria may or may not be related genetically or biochemically to the target bacteria. Those non- target bacteria of most interest in the context of the present application are non- pathogenic food-borne bacteria. The term "picking" refers to the process of removing a specified portion of a bacterial colony. As disclosed herein, the instant method provides a means whereby a specific and uniform number of bacterial cells is picked, thus leading to reproducibility of the instant method while minimizing spurious, non-specific results.
The term "dispersing buffer" means a buffer that maintains the cells intact and is useful for the dispersion of individual cells from a bacterial colony. Isotonic buffers such as buffered saline are particularly suitable.
The term "lysis buffer" as used herein refers to any aqueous solution suitable for use in the lysing of bacterial cells and releasing the cellular DNA.
The term "amplification reaction mixture" refers to the mixture of all the reagents and cellular material necessary to perform primer directed amplification of target DNA. Typically the amplification reaction mixture results from the mixing of the lysis buffer containing cellular DNA and the nucleic acid amplification composition.
The term "amplification product mixture" refers to the mixture formed after primer directed amplification has been performed on the amplification reaction mixture. If target DNA is present in the amplification reaction mixture, then the amplification product mixture will contain amplification products. The term "intercalating agent" means a temperature-sensitive fluorescent agent capable of intercalating into nucleic acid molecules. The term "intercalating agent" will be used interchangeably with the term "dye". Intercalating agents emit a fluorescent signal when intercalated into the nucleic acid and will not generate any signal when not intercalated. Typical of intercalating agents are the unsymetrical cyanine dyes such as YO-PRO-1 ™, available from Molecular Probes. Inc. (Eugene, OR. USA).
The term "threshold fluorescence" refers to the level of fluorescence above which the presence of dye-labeled target amplification products are confirmed. Threshold fluorescence is determined empirically by the analysis of a multiplicity of primer directed amplification reactions performed on both target and non-target bacteria.
The term "matrix" or "complex matrix" will refer to any organic or inorganic material that will support the growth of a variety of microorganisms. The matrices of the present invention will be complex in nature and will comprise of a variety of different organic growth-supporting substances. Typical matrices include components of food matter, biological tissues, organic waste products, and the like. The term "pre-enrichment growth" or "pre-enrichment culture" refers to the growth of target and non-target bacteria isolated from a complex matrix in a medium designed to resuscitate both classes of bacteria which have been injured or compromised by the sampling process. "Pre-enrichment media" will refer to cither a liquid or solid media designed to encourage the growth of both target and background bacteria. The pre-enrichment media of the present invention is buffered to allow for the variations in pH of a variety of different food matrices.
The term "selective growth" or "selective enrichment culture" refers to the growth of target and non-target bacteria isolated from a pre-enrichment culture in a selective media. The selective medium is designed to specifically encourage the growth of the target bacteria over the contaminating background or non-target bacteria. "Selective growth media" will refer to either a solid or liquid growth media specifically formulated to enhance the growth of the target bacteria and discourage the growth of background bacteria. Selective media capitalize on the specific nutrient requirements and the resistance to certain selective agents of the target bacteria to produce selective growth.
The term "sample analysate" refers to a sample of bacteria taken from a selective enrichment culture. Utility Statement The instant invention affords detection of target organisms, particularly bacteria, in the presence of contaminating food matrices and non-target bacteria. The method is particularly useful for the detection of pathogenic bacteria in the food preparation, agricultural and live stock industries, and also has application for medical and veterinary diagnostics. The present invention defines a process for the detection of target bacteria from a complex matrix by means of (i) target enrichment, consisting of consecutive pre-enrichment and selective cultures followed by (ii) colony picking, (iii) cell lysis, and finally (iv) amplification of target DNA. Amplification products are detected by means of a signal generated by an intercalating agent bound to the target amplification products. Target Enrichment
The minimum industry standard for the detection of food-borne bacterial pathogens is a method that will reliably detect the presence of one pathogen cell in 25 g of food matrix. In order to meet this stringent test, enrichment methods and media have been developed to enhance the growth of the target pathogen cell in order to facilitate its detection.
Typically at least two enrichment steps are preferred. The first step is a "pre-enrichment step" wherein the food sample is enriched in a nutritious. nonseiective broth medium to restore injured target cells to a stable condition and to promote growth. Next, a sample of the pre-enrichment broth is added to a selective enrichment broth, wherein the sample is further enriched in a growth- promoting medium containing selective reagents. Selective enrichment broth allows a continued increase of target bacteria while simultaneously restricting proliferation of most other background, non-target bacteria. Examples of selective media useful for the selective enrichment of Salmonella are tetrathionate broth and selenite cysteine broth. Media may be defined for virtually any known target bacteria, see for example Bacteriological Analytical Manual. 8th Edition. Association of Official Analytical Chemists. Arlington, VA (1995).
Although the above process for target enrichment is typical, it will be appreciated that it represents only one possible method and that other systems for the selective enrichment of a specified target bacteria will be dependent on the unique requirements of the specific target, all of which is well known to the skilled artisan in combination with standard protocols as given in the Bacteriological Analytical Manual supra. Colony generation
Following target cell enrichment, samples of the selective cultures are plated on a solid medium for colony generation. Solid media are selected so as to further enrich the growth of target bacteria while inhibiting the growth of background or non-target species. A variety of media are known in the art. For example, media that are particularly suited for the selection of Salmonella over background bacteria include xylose lysine desoxycholate (XLD). bismuth sulfite (BS), and Hektoen enteric (HE) agars. Methods of bacterial plating are common and well known in the art and a variety of suitable solid media are commercially available and in the public domain (see for example Sambrook. J. et al., Molecular Cloning: A Laboratory Manual. Second Edition, Cold Spring Harbor Laboratory Press (1989); Bacteriological Analytical Manual. 6th Edition, Association of Official Analytical Chemists, Arlington, VA ( 1984)). Colony Picking
Colonies grown on solid media are picked, lysed and submitted to a protocol for primer directed amplification of target DNA. The method of picking the colonies is an essential element of the present invention. The present method allows for the optimum number of cells to be submitted to the primer directed amplification protocol. Higher numbers of cells result in excessive fluorescent background and the introduction of materials known to inhibit DNA amplification. Lower numbers of cells result in insufficient amplification of target DNA.
Colonies were picked using a 5 uL glass capillary tube. Capillary tubes having an outside diameter ("O.D.") of between 0.026 in. and 0.0965 in are preferred in the present invention where an O.D. of about 0.0375 in. is most preferred. The particular capillary chosen for the experiments described herein was a 5 uL Microcap capillary (Drummond Scientific Co., Broomall, PA) of about 1.26 inches in length. Picking colonies with this device delivered between lxl 06 and 2x107 cells to the lysis buffer. Other design aspects of these capillaries lend utility. The small size, both in length and diameter allow placement of at least 12 capillaries in a single tube for resuspension of the collected cells by vortexing. This allows for rapid processing of multiple colonies and greater reproducibility in resuspending cells as opposed to individual sample, manual methods. Further, this picking process eliminates the need for quantification methods such as optical density measurements, commonly used in biochemical assays to deliver the required number of cells. Also, the diameter of the capillary acts as a gauge which is used to determine whether a colony is large enough to yield the required number of cells. Finally, the inert nature of glass guards against release of PCR inhibitory chemicals from the picking device.
Primer Directed Amplification Of Target DNA
Target DNA may be from any source where it is of value to discern the presence of a double-stranded nucleic acid fragment that is unique to a particular organism or is defining for a specific genetic trait. In one embodiment of the instant invention, target DNA is amplified to produce target amplification products from pathogenic bacterial organisms known to contaminate food. Of particular interest will be DNA isolated from organisms such as members of the following genera: Listeria, Salmonella, Clostridium and Escherichia.
Applicants contemplate that amplification may be accomplished by any of several schemes known in this art, including but not limited to the polymerase chain reaction (PCR), ligase chain reaction (LCR) or strand displacement amplification (SDA). If PCR methodology is selected, the amplification composition would include for example, nucleotide triphosphates. two primers with appropriate sequences, suitable buffers, DNA polymerase and proteins. These reagents and details describing procedures for their use in amplifying nucleic acids are provided in U.S. Patent No. 4,683,202 and U.S. Patent No. 4,683,195. If LCR methodology is selected, then the nucleic acid amplification compositions would comprise, for example, a thermostable ligase. e.g.. T. aquaticus ligase. two sets of adjacent ohgonucleotides wherein one member of each set is complementary to each of the target strands. Tris-HCl buffer, KCl, EDTA. NAD, dithiothreitol and salmon sperm DNA. (See. for example. Tabor. S. and Richardson. C. C. (1985) Proc. Acad. Sci. USA 82, 1074- 1078). If the SDA methodology is employed, amplification may be accomplished using either one or two short primers containing a site for Hindi digestion, an exonuclease deficient DNA polymerase, Hindi restriction enzyme and the bases dGTP, dCTP. dTTP and deoxyadenosine 5'fa-thio]triphosphate (dATP[aS]. The SDA protocol including the necessary materials is outlined in Walker, et al., Proc. Natl. Acad. Sci. U.S.A., 89, 392, (1992).
It should be noted that all methods of preparing suitable target amplification products are sufficiently controlled so as to eliminate spurious non- target amplification artifacts such as primer-dimer fragments, triple helices and the like. Reagents necessary for target amplification may be supplied to the present method in either solution or in tableted form. For example, suitable tableted reagents for the PCR amplification of Salmonella specific target DNA are described in International Patent Application No. PCT US96/15085. Where fluorescence detection is chosen as a means for the detection of amplification products, it may be useful to incorporate "positive control" and "negative control" tableted reagents in order to calibrate the amplification reaction and the monitor background fluorescence. For example a "sample tablet" will contain all the necessary reagents to amplify a specified target DNA, including appropriate primers and a suitable DNA polymerase. "Positive control" tablets will contain all the reagents encompassed within the sample tablet with the addition of a specified amount of target DNA. Addition of the positive control tablet into the PCR reaction will result in the amplification of the target DNA within the tablet thereby providing a reference for both the PCR reaction and for fluorescence detection. The "negative control" tablet contains all the reagents encompassed in the sample tablet with the exception of the DNA polymerase. The presence of the negative control tablet in the PCR reaction serves as a reference control for background fluorescence. Intercalating Agents
The present method uses an intercalating agent capable of binding to dsDNA and emitting a fluorescent signal distinguishable from the signal generated when unbound or bound to single stranded DNA. A variety of suitable intercalating agents are known in the art such as propidium iodide (PI) and ethidium bromide (EB) (Sailer et al.. Cytometry ( 1996), 25(2), 164-172), Oxazole Yellow (EP 714986), TOTO (l .l'-(4,4,7.7-tetramethyl-4.7-diazaundeca- methylene)-bis-4-[3-methyl-2.3-dihydro-(benzo-1.3-thiazole)-2-methylidene]- quinolinium tetraiodide), a homodimer of thiazole orange (Axton et al.. Mol. Cell. Probes (1994), 8(3). 245-50) oxazole orange (YOYO; Srinivasan et al.. Appl. Theor. Electrophor. (1993). 3(5), 235-9) as well as the cyanine dyes (U.S. Patent No. 5,563.037). Preferred in the present method are the unsymmetrical cyanine dyes such as are discussed in U.S. Patent No. 5,563.037, U.S. Patent No. 5,534.416, and U.S. Patent No. 5,321,130 hereby incorporated by reference.
Cyanine dyes are particularly suited for use in the present method since they possess binding constants for DNA low enough not to inhibit amplification by most primer directed amplification methods but high enough to still give a detectable signal. Preferred binding constants for the cyanine dyes useful in the present invention are from about from about lxl 04 to about 5xl05 (molar1 ).
Most suitable is the cyanine dye YO-PRO-1™ (Quinolinium. 4-[(3- methyl-2(3H)-benzoxazolylidenc)methyl]-l-[3-(trimethylammonio)- propyl]-. diiodide) available from Molecular Probes, Inc. (Eugene. OR. USA).
YO-PRO- 1 ™ is particularly suited for use in the present invention due to its high extinction coefficient, near zero fluorescence when unbound, suitable binding affinity to double-stranded DNA and reasonable photostability. YO-PRO-1™ is sufficiently resistant to the elevated processing temperatures at the time intervals used to provide an effective signal in use.
The intercalating agent can be provided at any step of the method prior to fluorescence detection. For example, the intercalating agent may be present in the buffer into which cells comprising picked bacterial colonies are dispersed. In another embodiment, the intercalating agent can be present in the buffer containing the lysis reagent. In a further embodiment, the intercalating agent can be introduced into the method as a component of the amplification composition. Finally, the intercalating agent can be added to the amplification product mixture just prior to analysis by fluorescence detection.
The intercalating agent chosen for use in the instant method may be temperature sensitive; i.e., the binding affinity of the intercalating agent for dsDNA and hence the magnitude of the fluorescent signal emitted may vary with temperature. Accordingly, it is readily apparent to one skilled in the art that instrument calibration, positive and negative controls and samples must all be assayed under controlled temperature conditions. Alternatively, a mathematical algorithm may be developed in order to compensate for variations in ambient and calibration temperatures. For example, the following algorithm comprises a simple linear multiplier that calculates the fluorescence value at a standard calibration temperature (FIUc) as a function of the ambient temperature at which sample measurements are taken (t) and the fluorescence intensity units (FlUt) recorded at that temperature: FIUc = FIUt(TCF). wherein
FIUc = the calculated fluorescence value; FlUt = the measured fluorescence value at a given ambient temperature (t); and
TCF = ((0.25 + 0.05(t))/l .45. This algorithm produces a constant result over a temperature range of 15-35°C. Target amplification
In order to identify a target by the present method, bacterial, cells picked according to the above mentioned methods are lysed in a lysis buffer to release cellular DNA. DNA is then amplified according to a standard method for primer directed amplification. Typically. PCR is used and follows a standard thermo- cycling procedure in the presence of an appropriate nucleic acid amplification composition. A suitable nucleic acid amplification composition will contain for example, dATP. dCTP. dGTP, dTTP, target specific primers and a suitable polymerase. Primers will be selected to specifically amplify target DNA. If nucleic acid composition is in liquid form, suitable buffers known in the art are used. (Sambrook, J. et al., Molecular Cloning: A Laboratory Manual, Second Edition. Cold Spring Harbor Laboratory Press (1989)). If the composition is contained in a tabletted reagent, then typical tabletting reagents are included as described in PCT US96/15085.
The intercalating agent YO-PRO-1™ can be included in the PCR reaction. YO-PRO-1 ™ is added to the sample to give a final dye concentration of about 3 uM. Thermocycling proceeds according to typical cycling times and temperatures.
Description of the preferred embodiments
The method of the invention begins with the collection of samples suspected of containing target bacteria and submission of those samples to target enrichment protocols. Samples are first cultured in a non-selective pre- enrichment medium and incubated for about 24 hours at about 37 °C. Following pre-enrichment, samples of the pre-enrichment culture are diluted into a selective medium to enrich the growth of the target bacteria. Aliquots of the selective culture are then streaked on appropriate solid media for colony generation. A defined number of bacteria are then picked by means of an individual 5 uL capillary tube from at least one colony on each plate. Capillary tubes from each pick are deposited in a container and immersed in an suitable dispersing buffer. Optionally the dispersing buffer may contain an intercalating agent capable of intercalating into DNA and emitting a fluorescent signal. The container is then sealed and agitated to disperse the cells from the capillary tubes into the amplification composition.
Following agitation and dispersion of the cells, samples of the solution are contacted by a lysis buffer where the cells are lysed and cellular DNA is released. The lysis buffer may optionally contain an effective concentration of intercalating agent. Lysis of the cells may occur by any method, including differential osmotic pressure, mechanical means such as sonication or heat.
Reagents necessary for the primer directed amplification (typically PCR) of target DNA may be added after ceil lysis. Such reagents will typically include nucleotide triphosphates, two primers with appropriate sequences, suitable buffers, DNA polymerase and proteins. These reagents may be provided in either solution or tableted form. Preferred are the use of tableted PCR reagents. Three types of tablets are used: a sample tablet, a positive control tablet and a negative control tablet. Sample tablets contain all reagents necessary for the amplification of the target. Positive control tablets contain the same reagents as the sample tablet with the addition of a specified amount of target DNA. Negative control tablets contain the same reagents as the sample tablet with the exception of the DNA polymerase. All tablets are processed in the PCR reaction under identical conditions. The positive control tablet serves as a check on the efficacy of the reaction as well as a monitor of expected fluorescence levels. The negative control tablet is an indication of background fluorescence produced by non¬ productive PCR reagents.
Following addition of the PCR reagents, the amplification protocol is performed in a sealed reaction vessel. Sealing of the vessel is important to prevent carryover contamination. If target DNA is present, amplification products are produced and products are detected and quantified.
It will be appreciated that the present invention may also be practiced in kit form. A typical kit will provide all consumable/disposable elements required for multiple analyses. Components for a Kit may include for example. Microcap Tubes, Sample Tube Assemblies consisting of clear PCR tubes with PCR caps having sample PCR tableted reagents enclosed, Lysis Buffer, a Control Tablet Package consisting of a first set of capped PCR tubes having negative control PCR tableted reagents enclosed and a second set of capped PCR tubes having positive control PCR tableted reagents enclosed, a YO-PRO-1™ Package, and Calibration Tubes consisting of a first set of tubes filled with a 1 :258 dilution of Estapor® fluorescent pink polystyrene particles( Stock Code D0001852CF; Bangs Laboratories, Inc., Carmel, IN), and a second set of tubes filled with lysis buffer. The present invention is further defined in the following Example. It should be understood that this Example, while indicating a preferred embodiment of the invention, is given by way of illustration only. From the above discussion and this Example, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.
EXAMPLE GENERAL METHODS Procedures for primer directed amplification are well known in the art.
Techniques suitable for use in the following examples may be found in Sambrook, J. et al., Molecular Cloning: A Laboratory Manual. Second Edition, Cold Spring Harbor Laboratory Press (1989).
Materials and methods suitable for the maintenance and growth of bacterial cultures are well known in the art. Techniques suitable for use in the following examples may be found in Manual of Methods for General Bacteriology (Phillipp Gerhardt, R. G. E. Murray, Ralph N. Costilow. Eugene W. Nester, Willis A. Wood, Noel R. Krieg and G. Briggs Phillips, eds), American Society for Microbiology, Washington. DC. (1994) or Thomas D. Brock in Biotechnology: A Textbook of Industrial Microbiology. Second Edition (1989) Sinauer Associates. Inc., Sunderland, MA. or Bacteriological Analytical Manual. 8th Edition, Association of Official Analytical Chemists, Arlington. VA (1995). All reagents and materials used for the growth and maintenance of bacterial cells were obtained from Aldrich Chemicals (Milwaukee. WI), DIFCO Laboratories (Detroit, MI), GIBCO/BRL (Gaithersburg. MD). or Sigma Chemical Company (St. Louis. MO) unless otherwise specified.
A Perkin Elmer GeneAmp Cycler 9600 (Perkin-Elmer. Branchburg N.J.) was used for all PCR reactions.
The cyanine intercalating agent YO-PRO-1™ was obtained from Molecular Probes (Eugene. OR).
Salmonella-specific PCR reagents used in the following examples were obtained from Qualicon, L.L.C.. Wilmington. DE (part no. 17410530) and are included in the Salmonella screening kit (catalog number 17720519).
The meaning of abbreviations is as follows: "h" means hour(s), "min" means minute(s), "sec" means second(s), "d" means day(s), "uL" means microliters, "mL" means milliliters. "L" means liters. "FIU" means fluorescent intensity units. Cell Strains
The following Salmonella strains were used in the examples provided herein: S. enteritidis (737), S. typhimurium (897), S. virchow (1247). S. hadar ( 1268). 5. kedougou ( 1254), 5. Heidelberg ( 1239), 5. montevideo ( 1260). and S. infantis (732). Non-target background organisms employed herein include
Citrobacter diversus (2560). Citrobacter spp. (217). £ coli (5108), £ co// (51 1 1 ), Hafnia alvei (4965), Hafnia alvei (2010). Proteus mirabilis (2321 ), and Proteus vulgaris (2323). All bacterial strains were obtained from the Qualicon L.L.C. culture collection. Numbers in parentheses indicate internal Qualicon L.L.C. culture designations. Solid Selective Media
Three types of solid media were used for the generation of colonies from target (Salmonella) and non-target bacteria. They consisted of xylose iysine desoxycholate (XLD), bismuth sulfite (BS), and Hektoen enteric (HE) agars. Protocols for their preparation may be found in Bacteriological Analytical
Manual. 8th Edition, Association of Official Analytical Chemists. Arlington. VA
(1995).
Buffers and Amplification Reagents
Lysis buffer used in this example consisted of 50 mM Tris. 28 mM KCl , 3 mM MgCl2, 0.1% Triton X-100, pH 8.3 containing 3 uM YO-PRO- 1 ™. PCR reagent components consisted of:
36 nM of each of the following amplification primers:
SEQ ID NO: l 5 ' -TAG CCG GGA CGC TTA ATG CGG TTA AC- 3 ' SEQ ID NO:2 5 ' -CTT TAC CGC TTC CAG TGT GGC CTG AA- 3 '
3 mM of magnesium. 160 uM of dNTP, and 1 .5 units of Taq™ polymerase per assay. The PCR buffer was comprises 50 mM Tris. 28 mM KCl, 0.1 % Tween-20 buffer. pH 8.3. Fluorometer Calibration
A fluorometer, equipped with a tungsten-halogen lamp, a 485 nm excitation filter and a 535 nm emission filter was used for detection of fluorescence emitted from amplification product.
Reagents used for the calibration of the fluorometer are as follows: (i) DNA standard: 500 bp double strand DNA fragment (BioVentures. Inc.; Catalogue No. M500).
(ii) lysis/dye buffer: lysis buffer containing 3 uM YO-PRO- 1 ™. The DNA standard was prepared at three different concentrations: 0 ng DNA, 200 ng DNA/50 uL and 400 ng DNA/50 uL. A standard curve was generated by measuring the fluorescence emitted from the three concentrations of DNA standards. The mean value of all three readings for each concentration was calculated and the results are tabulated below in Table I:
TABLE I Calibration Results
[DNA] Signal Signal Signal Mean signal
Calibrator (ng/assay) (FIU) (FIU) (FIU) (FIU)
Level 1 0 0.025 0.031 0.024 0.027
Level 2 200 3.304 3.185 3.14 3.21
Level 3 400 6.244 5.764 5.708 5.905
Determination Of Threshold Fluorescence
In order to determine threshold values of fluorescence to distinguish YO-PRO- 1 ™ labeled amplification products, a multiple parameter combination study was conducted. Data from 620 Salmonella PCR assays in the presence of the intercalating dye YO-PRO-1™ were analyzed using both analysis of variance and histogram techniques (JMP: Statistical Discover Software. SAS Institute. Inc. Gary, NC) to determine the fluorescence threshold value for Salmonella. These analyses were done for each strain (Salmonella and non-Salmonella) and provided summaries of variance components. The results of analysis can be seen in the attached histogram. Figure 1. For Salmonella, a threshold value of 1.5 FIU was determined.
EXAMPLE Identification Of Salmonella From Mixed Cultures
The ability of the instant method to specifically identify each of a panel of eight different target Salmonella strains present in a mixed culture with non-target. non-Salmonella strains was determined.
One colony of each of the Salmonella strains was picked per test. A total of 1 1 colonies representing the non-Salmonella strains were picked and added to each of the tubes containing the individual Salmonella colonies. One control Salmonella strain was tested to monitor consistency of the method. The fluorescence (FIU) data were recorded and measured against a pre-determined threshold value for Salmonella. All assays were performed in triplicate. Assay for Salmonella by Fluorescence PCR Detection
A. The following Reagents and Accessories were employed: Salomella strains cultured on XLD plates Ηon-Salmonella strains cultured on HE, XLD, and BS plates Capillary tubes (5 uL size) Cell suspension tubes ( 1.5 mL, Eppendorf) Cell lysis tubes (2 mL capacity with screwcap) PCR vials (std. size - 0.2 mL) PCR sample tablets
PCR positive control tablets PCR negative control tablets YO-PRO-1™ reagent (5.26 mL/tube) Lysis buffer B. Equipment used in the instant example included:
1 ) Perkin Elmer GeneAmp™ 9600 thermal cycler
2) Heating water bath (up to 95 °C)
3) Fluorometer
C. Lysis/Dye solution was prepared as follows. A 3 uM YO-PRO-1™ solution was prepared by adding 1.75 mL of lysis buffer into the YO-PRO- 1 ™ tube (as received from the manufacturer). PCR reagents tubes were prepared by pipetting 1 mL lysis buffer and 200 uL of the 3 uM YO-PRO-1 ™ solution into tubes containing either a sample PCR tablet (experimental), a positive control tablet or a negative control tablet. D. Cell picking procedure.
The following Salmonella strains were separately cultured on XLD plates:
S. enteritidis (737), S. typhimurium (897), S. virchow ( 1247), S. hadar ( 1268),
S. kedougou ( 1254), S. heidelberg (1239), S. montevideo ( 1260), and S. infantis
(732). Each of following background bacterial strains were separately cultured on
XLD, HE and BS plates: Citrobacter diversus (2560), Citrobacter spp (217),
£ coli (5108), £ coli (51 1 1 ), Hafnia alvei (4965), Hafnia alvei (2010). Proteus mirabilis (2321), and Proteus vulgar is (2323).
Colonies were picked from the culture plates as follows: 1) The capillary container was held upside down and a capillary was removed from the hole by grasping one end. making sure not to touch the other end of the capillary.
2) One isolated colony was touched with the free end of the capillary by holding the capillary peφendicular to the plate and gently pressing in the center of the colony.
3) The capillary was removed from the colony and dropped into the cell suspension tube. Evaluation of ability of the instant method to detect target bacteria in the presence of non-target bacteria was performed by picking one target (Salmonella) bacterial colony and eleven non-target bacterial colonies to the same tube. Colonies of non-target bacteria were picked at random. The tube was then capped and vortexed at full speed for at least 5 seconds. This method of picking was repeated for each Salmonella strain tested. Assay response to each of the non- target bacterial strains was measured by picking twelve colonies of the same non- target strain to a single assay tube. Colonies of non-target bacteria were picked so that four colonies growing on each of the three growth media were picked to the same tube. This picking protocol was repeated for all of the non-target bacterial strains tested. E. Cell Lysis:
Cell lysis was performed as follows:
1 ) 10 uL of each colony suspension was removed from each sample tube and placed in a lysis tube containing 190 uL of lysis/dye solution.
2) Each tube was tightly capped and vortexed to mix the contents.
3) Tubes were incubated for 10 min in a water bath at 95°C.
4) Following the incubation period, samples were allowed to cool to room temperature. F. PCR Amplification
PCR amplification was performed as follows: 1 ) The thermal cycler was programmed as follows:
HOLD: 94 °C for 2 min., one cycle
CYCLE: 94 °C for 15 seconds, 72 °C for 2 min.,
35 cycles
HOLD: 72 °C for 7 min., one cycle
HOLD: 25 °C forever.
Sample vol.: 50 uL 3) 50 uL of each lysed sample was pipetted into each PCR sample tube.
4) 50 uL of each sample was pipetted into positive and 50 uL into negative control PCR tubes.
5) All tubes were capped and placed into the thermal cycler, and the program was initiated. G. Fluorescence Detection
The fluorometer was permitted to warm up and was calibrated. PCR reaction samples were removed from the thermal cycler and allowed to cool to room temperature. Samples were read at an excitation of 485 nm and an emission of 535 nm Readings were compared against a previously determined threshold value
H Inteφretation of Data
The PCR Fluorescence threshold value tor Salmonella was previously determined to be 1 5 FIU As an internal control, the positive control PCR fluorescence reading was maintained above threshold and the negative control PCR was maintained below the threshold
Any sample PCR fluorescence reading that equaled or exceeded the threshold value was read as positive, indicating the presence of an amplification product Where the reading was less than the threshold value, the result was negative, indicating no amplification product generated Results are tabulated in Table II
1 ABLE II
Sample No Bacterial species PCR product signal (FIU)
1 S enterttdis 737 7 1
2 5 typhtmurtum 897 6 7
3 S vtchow 1247 6 3
4 S hadar 1268 7 2
5 S kedogou 1254 5 7
6 S Heidelberg 1239 6 2
7 S Montevideo 1260 6 9
8 S infantis 732 6 3
9 Citrobacter diversus 2560 0 65
10 Citrobacter sp 217 0 5
Figure imgf000022_0001
12 £ cø/; 5108 0 62
13 Hafnia alvei 4965 0 79
14 Hafnia alvei 2010 0 72
15 Proteus mirabilhs 2321 0 59
16 Proteus vulgaris 2323 0 56
As can be seen from the data presented above, the PCR product signal in all eight Salmonella species (Sample Nos 1-8) was above the established threshold (1 5 FIU) The PCR product fluorescence signal in all non-Salmonella species (Sample Nos 9-16) was well below the threshold Thus the present method was effective in confirming the presence target colonies, even in the context of at several fold greater numbers of non-target bacteria SEQUENCr LISTING
(1) GENERAL INTORMATION:
(l) APPLICANT: TSENG, SUSAN YEN-TEE BARBOUR, WILLIAM MARK
(il) TITLE OF INVENTION: IDENTIFICATION OF TARGET
BACTERIA BY FLUORESCENCE DETECTION Or PRIMER DIRECTED AMPLIFICATION PRODUCTS
(in) NUMBER OF SEQUENCES: 2
(iv) CORRESPONDENCE ADDRESS:
(A) ADDRESSEE: E. I. DUPONT DE NEMOURS AND COMPANY
(B) STREET: 1007 MARKET STREET
(C) CITY: WILMINGTON
(D) STATE: DELAWARE
(E) COUNTRY: UNITED STATES OF AMERICA fF) ZIP: 19898
(v) COMPUTER READABLE FORM:
»A) MEDIUM TYPE: DISKETTE, J . ^0 INC!
(P) COMPUTER: IBM PC COMPATIBLF
(C) OPERATING SYSTEM: MICROSOFT WINDOWS 9C
(0) SOFTWARE: MICROSFOT WORD FOR WINDOWS 9o
(vi) CURRENT APPLICATION DATA
(A) APPLICATION NUMBER:
(B) FILING DATE:
(C) CLASSIFICATION:
(vii) PRIOR APPLICATION DATA:
(A) APPLICATION NUMBER. OΘ/650074
(B) FILING DATE: MAY 17, 1996
(vm) ATTORNEY/AGENT INFORMATION:
(A) NAME: MAJARIAN, WILLIAM R.
(B) REGISTRATION NUMBER: 41,173
(C) REFERENCE/DOCKET NUMBER: MD-1064-A
(ix) TELECOMMUNICATION INFORMATION:
(A) TELEPHONE: 302-992-4926
(B) TELEFAX: 302-773-0164
(2) INFORMATION FOR SFQ ID NO:l;
( ; SEQUENCE CHARACTERISTICS:
(A) LENGTH: 26 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: sinqle
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (uenomic) (in) HYPOTHETICAL: NO
(iv) ANTI-SENSE: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: TAGCCGGGAC CCTTAATGCG GTTAAC 26
(2) INFORMATION FOR SEO ID NO: 2:
(l) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 26 base pairs
Figure imgf000024_0001
(C) STRANDEDNESS: sinqle
(D) TOPOLOGY: linear
(ID MOLECULE TYPE: DNA (genomic)
(ill) HYPOTHETICAL: NO
(iv) ANTI-SENSF: NO
(xi) SEQUENCE DESCRIPTION: SEQ TD NO:2:
CTTTACCGCT TCCAGTGTGG CCTGAA 26
"?->

Claims

What is claimed is:
1. A method for identifying a target bacterium in a sample analysate, the analysate suspected of containing the target bacterium and having been cultured to produce at least one colony, the method comprising the steps of: (i) picking at least a portion of a bacterial colony by means of an individual capillary tube;
(ii) dispersing the cells comprising the colony of step (i) into a suitable dispersing buffer;
(iii) lysing the dispersed cells of step (ii) by contacting the dispersed cells with an effective amount of lysis buffer such that the DNA contained within the dispersed cells is released;
(iv) producing an amplification reaction mixture by contacting the DNA released in step (iii) with a nucleic acid amplification composition comprising amplification primers useful for amplification of target DNA; (v) performing primer directed amplification on the released DNA of step
(iii) to produce an amplification product mixture; and
(vi) analyzing the amplification product mixture for the presence of target amplification products wherein the target amplification products contain an intercalating agent, the intercalating agent added at any time before step (vi).
2. The method of Claim 1 wherein the capillary tube a five microliter tube.
3. The method of Claim 2 wherein the capillary tube has an O.D. from about 0.026 inches to about 0.0965 inches.
4. The method of Claim 3 wherein the capillary tube has an O.D. of about 0.0375 inches.
5. The method of Claim 1 wherein the picking results in removal of from about lxl 0^ to about 2xl 07 cells from the colony.
6. The method of Claim 1 wherein the primer directed amplification is a member selected from the group consisting of polymerase chain reaction, ligase chain reaction and strand displacement amplification.
7. The method of Claim 1 wherein the amplification primers amplify a unique portion of the genome a bacterial genus, the genus selected from the group consisting of Salmonella. Listeria. Eschericia, and Clostridium.
8. The method of Claim 1 wherein the intercalating agent is an unsymmetrical cyanine dye.
9. The method of Claim 8 wherein the unsymmetrical cyanine dye is YO-PRO-1™.
2 3
SUBSTITUTE SHEET (RULE 2B)
PCT/US1997/007958 1996-05-17 1997-05-09 Identification of target bacteria by fluorescence detection of primer directed amplification products WO1997044486A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU29391/97A AU2939197A (en) 1996-05-17 1997-05-09 Identification of target bacteria by fluorescence detection of primer directed amplification products
EP97923627A EP0904408A1 (en) 1996-05-17 1997-05-09 Identification of target bacteria by fluorescence detection of primer directed amplification products
CA002255760A CA2255760A1 (en) 1996-05-17 1997-05-09 Identification of target bacteria by fluorescence detection of primer directed amplification products
JP09542467A JP2001501454A (en) 1996-05-17 1997-05-09 Identification of target bacteria by fluorescence detection of primer-controlled amplification products

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65007496A 1996-05-17 1996-05-17
US08/650,074 1996-05-17

Publications (1)

Publication Number Publication Date
WO1997044486A1 true WO1997044486A1 (en) 1997-11-27

Family

ID=24607341

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/007958 WO1997044486A1 (en) 1996-05-17 1997-05-09 Identification of target bacteria by fluorescence detection of primer directed amplification products

Country Status (5)

Country Link
EP (1) EP0904408A1 (en)
JP (1) JP2001501454A (en)
AU (1) AU2939197A (en)
CA (1) CA2255760A1 (en)
WO (1) WO1997044486A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1215286A2 (en) * 2000-12-14 2002-06-19 Hitachi Software Engineering Co., Ltd. Detection method and detection kit for PCR-amplified base sequences
US8309308B2 (en) 2004-07-29 2012-11-13 Lumora Limited Method for determining the amount of template nucleic acid present in a sample
US8828680B2 (en) 1999-04-29 2014-09-09 Siemens Healthcare Diagnostics Inc. Combined rapid susceptibility assay and microorganism identification system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512334A2 (en) * 1991-05-02 1992-11-11 F. Hoffmann-La Roche Ag Methods for detecting a target nucleic acid in a sample
GB2282138A (en) * 1993-09-28 1995-03-29 Tosoh Corp Method of extracting nucleic acids and detecting specified nucleic acid sequences
EP0684316A1 (en) * 1994-04-29 1995-11-29 Johnson & Johnson Clinical Diagnostics, Inc. Homogeneous method for assay of double-stranded nucleic acids using fluorescent dyes and kit useful therein
WO1997011197A1 (en) * 1995-09-20 1997-03-27 E.I. Du Pont De Nemours And Company Control for pcr

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512334A2 (en) * 1991-05-02 1992-11-11 F. Hoffmann-La Roche Ag Methods for detecting a target nucleic acid in a sample
GB2282138A (en) * 1993-09-28 1995-03-29 Tosoh Corp Method of extracting nucleic acids and detecting specified nucleic acid sequences
EP0684316A1 (en) * 1994-04-29 1995-11-29 Johnson & Johnson Clinical Diagnostics, Inc. Homogeneous method for assay of double-stranded nucleic acids using fluorescent dyes and kit useful therein
WO1997011197A1 (en) * 1995-09-20 1997-03-27 E.I. Du Pont De Nemours And Company Control for pcr

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828680B2 (en) 1999-04-29 2014-09-09 Siemens Healthcare Diagnostics Inc. Combined rapid susceptibility assay and microorganism identification system
EP1215286A2 (en) * 2000-12-14 2002-06-19 Hitachi Software Engineering Co., Ltd. Detection method and detection kit for PCR-amplified base sequences
EP1215286A3 (en) * 2000-12-14 2002-06-26 Hitachi Software Engineering Co., Ltd. Detection method and detection kit for PCR-amplified base sequences
US8309308B2 (en) 2004-07-29 2012-11-13 Lumora Limited Method for determining the amount of template nucleic acid present in a sample

Also Published As

Publication number Publication date
CA2255760A1 (en) 1997-11-27
AU2939197A (en) 1997-12-09
EP0904408A1 (en) 1999-03-31
JP2001501454A (en) 2001-02-06

Similar Documents

Publication Publication Date Title
Olive Detection of enterotoxigenic Escherichia coli after polymerase chain reaction amplification with a thermostable DNA polymerase
Hoorfar et al. Automated 5′ nuclease PCR assay for identification of Salmonella enterica
Malorny et al. Standardization of diagnostic PCR for the detection of foodborne pathogens
Bai et al. Rapid and reliable detection of 11 food-borne pathogens using thin-film biosensor chips
AU783278B2 (en) Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
Cunningham et al. Rapid PCR detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum
Köster et al. Analytical methods for microbiological water quality testing
US9416398B2 (en) Generic buffer for amplification
US20070031866A1 (en) Detection of Vancomycin-Resistant Enterococcus spp.
EP1338656A1 (en) Detection of group A streptococcus
Jannes et al. A review of current and future molecular diagnostic tests for use in the microbiology laboratory
CN101563455B (en) Primer and probe for detection of mycobacterium avium and method for detection of mycobacterium avium by using the primer or probe
Vasavada et al. Conventional and novel rapid methods for detection and enumeration of microorganisms
WO1998036096A1 (en) Detection of double-stranded dna in a homogeneous solution
Boel et al. Evaluation of conventional and real-time PCR assays using two targets for confirmation of results of the COBAS AMPLICOR Chlamydia trachomatis/Neisseria gonorrhoeae test for detection of Neisseria gonorrhoeae in clinical samples
Sandin Polymerase chain reaction and other amplification techniques in mycobacteriology
US20050282194A1 (en) Detection of Shiga toxin- or Shiga-like toxin-producing organisms
EP0851941B1 (en) Control for pcr
Abu-Halaweh et al. Rapid detection and differentiation of pathogenic Campylobacter jejuni and Campylobacter coli by real-time PCR
US6013435A (en) Drug resistance screening method using multiplex amplification
CN113604588A (en) Method, primer group, colloidal gold test strip and kit for rapidly detecting vibrio cholerae based on MIRA technology
EP0696638A1 (en) Process for lysing mycobacteria
MXPA03012075A (en) Methods and oligonucleotides for the detection of $i(salmonella) sp., $i(e. coli) o157:h7, and $i(listeria monocytogenes ).
EP0904408A1 (en) Identification of target bacteria by fluorescence detection of primer directed amplification products
Wang et al. Nanoparticles-based lateral flow biosensor coupled with multiple cross displacement amplification Plus for simultaneous detection of nucleic acid and prevention of carryover contamination

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE HU IL IS JP KG KP KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK TJ TM TR TT UA US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997923627

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 542467

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref document number: 2255760

Country of ref document: CA

Ref country code: CA

Ref document number: 2255760

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1997923627

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997923627

Country of ref document: EP